Vaccine ProtocolsAndrew P. Robinson, Martin P. Cranage, Michael J. Hudson Springer Science & Business Media, 2008 M02 1 - 416 páginas Vaccine research and development is advancing at an unprecedented pace, with an increasing emphasis on rational design based upon a fundamental und- standing of the underlying molecular mechanisms. The aim of this volume is to provide a selection of contemporary protocols that will be useful to both novice and advanced practitioner alike. The variety of procedures required to design, develop, produce, and assess a vaccine is immense and covers aspects of ch- istry, biochemistry, molecular biology, cell biology, and immunology. No single volume can hope to cover these topics exclusively. Rather, here we attempt to provide a methods sourcebook focusing on hands-on practical advice. Comp- mentary and background information may be found in other volumes in the Me- ods in Molecular Medicine series. Of particular interest are volumes on Dendritic Cell Protocols, Interleukin Protocols, Vaccine Adjuvants, and DNA Vaccines. Since the publication of the first edition of Vaccine Protocols there have been major advances, particularly in the areas of bacterial genomics, antig- specific T-cell quantification, genetic manipulation of vaccine vectors, the h- nessing of natural molecules concerned with the regulation of immune responses, and the burgeoning field of DNA vaccinology. Hence, the extensive revision of this edition with new chapters on live viral vaccine vectors, atte- ated bacterial vectors, immunomodulators, MHC-peptide tetrameric complexes, and the identification of vaccine candidates by genomic analysis. Additionally, chapters from the first edition have been updated to accommodate state-of-t- art methods in vaccinology. |
Contenido
1 | |
2 TemperatureSensitive Mutant Vaccines | 19 |
Construction of a ReplicationDeficient Recombinant Adenovirus | 37 |
Vaccinia Virus | 51 |
Semliki Forest Virus | 69 |
6 Development of Attenuated Salmonella Strains That Express Heterologous Antigens | 83 |
7 Expression and Delivery of Heterologous Antigens Using Lactic Acid Bacteria | 101 |
8 Synthetic Peptides | 115 |
Current Trends | 223 |
15 Stimulation of Mucosal Immunity | 245 |
16 Induction and Detection of TCell Responses | 255 |
17 Construction of MHC Class IPeptide Tetrameric Complexes for Analysis of TCellMediated Immune Responses | 279 |
18 Assessment of Functional Antibody Responses | 289 |
19 The Use of Complete Genome Sequences in Vaccine Design | 301 |
20 Severe Combined Immunodeficient SCID Mice in Vaccine Assessment | 313 |
21 Clinical Trials | 335 |
9 Genetic Detoxification of Bacterial Toxins | 133 |
10 Preparation of PolysaccharideConjugate Vaccines | 153 |
11 Adjuvant Formulations for Experimental Vaccines | 175 |
12 Incorporation of Immunomodulators into Plasmid DNA Vaccines | 195 |
13 Microencapsulation of Vaccine Antigens | 211 |
Regulatory Expectations for Licensing and Batch Release | 353 |
An Update | 377 |
A Guide for the Researcher | 391 |
409 | |
Otras ediciones - Ver todas
Vaccine Protocols Andrew P. Robinson,Martin P. Cranage,Michael J. Hudson Sin vista previa disponible - 2003 |
Vaccine Protocols Graham H. Farrar,Andrew Robinson,Christopher N. Wiblin Sin vista previa disponible - 1996 |
Vaccine Protocols Andrew P. Robinson,Martin P. Cranage,Michael J. Hudson Sin vista previa disponible - 2010 |
Términos y frases comunes
acid adenovirus adjuvant agar ampicillin antibody antibody responses antigen assay attenuated bacterial biological buffer carrier cells centrifuge cholera clinical trials cloning coli concentration conjugate vaccines containing culture cytokine dilution disease DNA vaccines dose efficacy electroporation ELISA epitopes Escherichia coli evaluation expression freeze-drying gene genetic genome human immune responses immunodeficiency immunogenicity Immunol immunological inactivation incubate induce infection influenza inoculation laboratory measles medium method mice microparticles Molecular molecules monolayers mouse mucosal mutagen mutants nisin Note oral peptide Phase plaque plasmid plasmid DNA plates pneumococcal polysaccharide preparation primers production protection protein Protocols purified reagents recombinant respiratory syncytial virus resuspend room temperature Salmonella sample SCID SDS-PAGE sequence serum solution specific stability sterile strain studies Subheading subunit supernatant synthetic T-cell tetanus tion titer toxin toxoid transfection tube vaccinia vector viral Virol virus viruses vivo Wash µg/mL